14.03.2024 – 07:31STADA Arzneimittel AGPress release: STADA continues with double-digit sales and profit growth in 2023One documentmore
09.01.2024 – 11:02STADA Arzneimittel AGPress release: Zuellig Pharma becomes STADA Philippines’ exclusive distribution partnerOne documentmore
12.12.2023 – 09:17STADA Arzneimittel AG3Press release: STADA further improves Sustainability ranking; rates among top 6% of pharma players globallyOne documentmore
22.11.2023 – 17:08STADA Arzneimittel AGPress release: STADA strikes partnership with CR Sanjiu in China to drive growth of its cough and cold portfolioOne documentmore
30.08.2023 – 12:28STADA Arzneimittel AG2Press release : People with Parkinson’s experience variations in effects of oral medicines, but lack advice, international survey revealsOne documentmore
15.08.2023 – 07:01STADA Arzneimittel AG2Press release: STADA's excellent results in H1 2023 indicate a record annual profit of €1 bn, driven by Consumer Healthcare and SpecialtyOne documentmore
12.07.2023 – 08:30STADA Arzneimittel AGPress release : STADA further grows its European Consumer Healthcare portfolio by acquiring several additional brands from SanofiOne documentmore
15.06.2023 – 13:20STADA Arzneimittel AGPress release: STADA appoints Christos Gallis as Head of Eastern EuropeOne documentmore
06.03.2023 – 09:42STADA Arzneimittel AGPress release: STADA sustains strong momentum with double-digit sales and profit growth in 2022One documentmore
02.01.2023 – 10:01STADA Arzneimittel AGPress release: STADA appoints Boris Döbler as Chief Financial OfficerOne documentmore
20.12.2022 – 10:02STADA Arzneimittel AG3Press release: STADA ranks among top 10% of pharma firms on sustainabilityOne documentmore
28.11.2022 – 10:40STADA Arzneimittel AG3Press release: STADA starts work on >EUR50m facility to strengthen European medicines supplyOne documentmore
23.11.2022 – 12:11STADA Arzneimittel AGPress release: Stéphane Jacqmin joins STADA from Sanofi and becomes Head of Emerging MarketsOne documentmore